- Home
- CPD Activities
- Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults
Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults
| Name | INFECTIOUS DISEASES INSTITUTE |
|---|
| Activity Title | Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults |
|---|
| Details | Journal Club |
|---|
| Competence | General Medicine |
|---|
| Start Date | 26-02-2024 |
|---|
| End Date | 26-02-2024 |
|---|
| Event Time | 08:45 AM |
|---|
| Location | Hybrid |
|---|
| Cost (UGX) | 0 |
|---|
| CPD Points | 1 |
|---|